Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommerer

Showing results (361-370 of 427) with videos related to

Pageof 43
Sort By:
Transplantation|July 13, 2010
Does borderline kidney allograft rejection always require treatment?Dorottya Németh, Jörg Ovens, Gerhard Opelz, et al.
Clinical Nephrology|April 25, 2013
A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 yearWolfgang Arns, Claudia Sommerer, Petra Glander, et al.
Biochemical and Biophysical Research Communications|May 8, 2014
Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancerChristina U Köhler, Laura Martin, Nadine Bonberg, et al.
Atherosclerosis. Supplements|August 27, 2019
Effectiveness of different immunoadsorption columns for anti-A/B antibody depletionClaudius Speer, Florian Kälble, Luiza Pego da Silva, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 18, 2016
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot StudyR A Montgomery, B J Orandi, L Racusen, et al.
European Journal of Epidemiology|January 25, 2021
The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristicsAndré Karch, Daniela Schindler, Andrea Kühn-Steven, et al.
BMC Nephrology|June 30, 2018
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS studyUte Eisenberger, Klemens Budde, Frank Lehner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2020
Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKDDominik Steubl, Markus P Schneider, Heike Meiselbach, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 28, 2023
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney DiseaseVladimir Cejka, Stefan Störk, Jennifer Nadal, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2012
Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS studyK Budde, F Lehner, C Sommerer, et al.
Pageof 43

Showing results (361-370 of 427) with videos related to

Sort By:
Pageof 43
Transplantation|July 13, 2010
Does borderline kidney allograft rejection always require treatment?Dorottya Németh, Jörg Ovens, Gerhard Opelz, et al.
Clinical Nephrology|April 25, 2013
A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 yearWolfgang Arns, Claudia Sommerer, Petra Glander, et al.
Biochemical and Biophysical Research Communications|May 8, 2014
Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancerChristina U Köhler, Laura Martin, Nadine Bonberg, et al.
Atherosclerosis. Supplements|August 27, 2019
Effectiveness of different immunoadsorption columns for anti-A/B antibody depletionClaudius Speer, Florian Kälble, Luiza Pego da Silva, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 18, 2016
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot StudyR A Montgomery, B J Orandi, L Racusen, et al.
European Journal of Epidemiology|January 25, 2021
The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristicsAndré Karch, Daniela Schindler, Andrea Kühn-Steven, et al.
BMC Nephrology|June 30, 2018
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS studyUte Eisenberger, Klemens Budde, Frank Lehner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2020
Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKDDominik Steubl, Markus P Schneider, Heike Meiselbach, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 28, 2023
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney DiseaseVladimir Cejka, Stefan Störk, Jennifer Nadal, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2012
Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS studyK Budde, F Lehner, C Sommerer, et al.
Pageof 43